D. Tural Et Al. , "Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab," International Journal of Clinical Oncology , vol.26, no.8, pp.1506-1513, 2021
Tural, D. Et Al. 2021. Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab. International Journal of Clinical Oncology , vol.26, no.8 , 1506-1513.
Tural, D., ÖLMEZ, Ö. F., Sümbül, A. T., Özhan, N., Çakar, B., Köstek, O., ... EKENEL, M.(2021). Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab. International Journal of Clinical Oncology , vol.26, no.8, 1506-1513.
Tural, Deniz Et Al. "Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab," International Journal of Clinical Oncology , vol.26, no.8, 1506-1513, 2021
Tural, Deniz Et Al. "Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab." International Journal of Clinical Oncology , vol.26, no.8, pp.1506-1513, 2021
Tural, D. Et Al. (2021) . "Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab." International Journal of Clinical Oncology , vol.26, no.8, pp.1506-1513.
@article{article, author={Deniz Tural Et Al. }, title={Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab}, journal={International Journal of Clinical Oncology}, year=2021, pages={1506-1513} }